Aristea Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://aristeatx.com
Clinical Trials
9
Active:3
Completed:3
Trial Phases
2 Phases
Phase 1:5
Phase 2:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (55.6%)Phase 2
4 (44.4%)A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
- First Posted Date
- 2022-07-07
- Last Posted Date
- 2023-02-13
- Lead Sponsor
- Aristea Therapeutics, Inc.
- Registration Number
- NCT05448391
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Aristea Therapeutics, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT05348681
- Locations
- 🇺🇸
Cahaba Dermatology & Skin Center, Birmingham, Alabama, United States
🇺🇸Investigate MD, LLC, Scottsdale, Arizona, United States
🇺🇸USC IDS Pharmacy, Los Angeles, California, United States
A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)
- First Posted Date
- 2022-01-18
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Aristea Therapeutics, Inc.
- Target Recruit Count
- 79
- Registration Number
- NCT05194839
- Locations
- 🇺🇸
Total Skin & Beauty Dermatology Center, PC, Birmingham, Alabama, United States
🇺🇸Dermatology Trial Associates, Bryant, Arkansas, United States
🇺🇸Cosmetic Laser Dermatology, San Diego, California, United States
A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2022-01-10
- Lead Sponsor
- Aristea Therapeutics, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05023811
- Locations
- 🇬🇧
Quotient Sciences Ltd, Nottingham, United Kingdom
A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- Aristea Therapeutics, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT04105959
- Locations
- 🇬🇧
MAC Clinical Research, Manchester, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found